Orabloc Articaine HCl 4% with Epinephrine 1:200,000 Injection Cartridges, 1.8 mL 50/Pk
2101052
- In stock, ready to ship
- Inventory on the way
Orabloc Articaine HCl 4% with Epinephrine 1:200,000 Injection Cartridges, 1.8 mL 50/Pk
Description
Orabloc® is an amide local anesthetic containing a vasoconstrictor indicated for local, infiltrative or conductive anesthesia in both simple and complex dental procedures.
- Articaine Hydrochloride 4% with Epinephrine
- Rapid onset of anesthesia within 1-9 minutes
- Complete anesthesia lasts about 1 hour for infiltration, up to 2 hours for nerve block
- 24-month shelf life at room temperature
- Very low manufacture-related degradation products such as articaine acid and epinephrine sulphonic acid
- Sodium edetate free, methylparaben free and latex free
- Each Orabloc® cartridge is sealed individually in the blister for maximum protection during storage and handling
Specifications
Manufacturer: | Pierrel Pharma |
Manufacturing Code: | 2101052 |
MSRP: | $59.99 |
Quantity: | 50/bx |
Item - Concentration: | 1:200,000 |
Item - Percent Anesthetic: | 4% |
Order processing time: 1-2 business days for order to process and shipped.
Delivery carriers: UPS, FedEx and USPS. Tracking details will be provided to the customer via email.
RETURNS:
No Risk Returns. We stand by our products 100%. If you wish to return your new or unused product within 30 days of ordering we’ll accept the return and issue a refund on the product.
Please inspect your order immediately upon arrival. For returns, please fill out and submit our return authorization form. We will contact you within one business day with your return authorization number & a shipping label. The cost of the shipping label will be deducted from the refund. You may return the product within 30 days of receipt as long as the product is returned in new, unused and in resellable condition. Customized items are not eligible for a refund unless there was an error on our end.
All infection control product sales are final and not eligible of a refund.